Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Corbus Pharmaceuticals Hldgs Inc (CRBP)

Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

CRBP : 7.35 (-2.52%)
Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair

AKTX : 1.2600 (+0.41%)
QURE : 15.01 (-1.44%)
CRBP : 7.35 (-2.52%)
Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference

CRBP : 7.35 (-2.52%)
Corbus Pharmaceuticals: Q1 Earnings Snapshot

Corbus Pharmaceuticals: Q1 Earnings Snapshot

CRBP : 7.35 (-2.52%)
Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update

CRBP : 7.35 (-2.52%)
Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity

CRBP : 7.35 (-2.52%)
Corbus Pharmaceuticals: Q4 Earnings Snapshot

Corbus Pharmaceuticals: Q4 Earnings Snapshot

CRBP : 7.35 (-2.52%)
Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update

CRBP : 7.35 (-2.52%)
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences

CRBP : 7.35 (-2.52%)
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025

CRBP : 7.35 (-2.52%)

Barchart Exclusives

Coffee Prices Hit a 5-Week Low on Higher Supply Fears. How to Trade It.
Rains in Brazil and more offtake from Vietnam are boosting supply prospects for coffee. This is bearish for coffee futures prices. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar